SHANGHAI (Reuters) -Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will mark the French drugmaker's largest single investment in ...

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

A Feature on M&A, licensing, and partnership tapping into AI’s potential to improve drug development.

Lenacapavir will be available at low cost in 120 poor countries. But nearly all of Latin America was excluded from a deal ...